TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis
New data from McGill University illuminate research in tuberculosis
December 30th, 2008
According to recent research published in the European Respiratory Journal, "The global extensively drug-resistant tuberculosis (TB) response plan calls for implementation of rapid tests to screen patients at risk of drug-resistant TB. Currently, two line probe assays exist, the INNO-LiPA (R) Rif.TB assay (Innogenetics, Ghent, Belgium) and the GenoType (R) MTBDR assay (Hain LifeScience GmbH, Nehren, Germany)." "While LiPA studies have been reviewed, the accuracy of GenoType assays has not been systematically reviewed. The present authors carried out a systematic review and used meta-analysis methods appropriate for diagnostic accuracy. After the literature...
Source: TB & Outbreaks Week (2008-12-30)
|
